 Neurotransmitter Agents
"Neurotransmitter Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.
| Descriptor ID |
D018377
|
| MeSH Number(s) |
D27.505.519.625 D27.505.696.577
|
| Concept/Terms |
Neurotransmitters- Neurotransmitters
- Transmitter Substances, Nerve
- Substances, Nerve Transmitter
- Nerve Transmitter Substances
- Neurotransmitter
|
Below are MeSH descriptors whose meaning is more general than "Neurotransmitter Agents".
Below are MeSH descriptors whose meaning is more specific than "Neurotransmitter Agents".
This graph shows the total number of publications written about "Neurotransmitter Agents" by people in this website by year, and whether "Neurotransmitter Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 1 | 1 | 2 | | 1985 | 1 | 0 | 1 | | 1986 | 1 | 0 | 1 | | 1988 | 1 | 0 | 1 | | 1989 | 1 | 0 | 1 | | 1990 | 2 | 1 | 3 | | 1991 | 1 | 1 | 2 | | 1993 | 1 | 1 | 2 | | 1994 | 1 | 0 | 1 | | 1995 | 0 | 2 | 2 | | 1996 | 0 | 1 | 1 | | 1997 | 4 | 1 | 5 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 3 | 1 | 4 | | 2002 | 2 | 2 | 4 | | 2003 | 4 | 1 | 5 | | 2005 | 2 | 2 | 4 | | 2006 | 4 | 5 | 9 | | 2007 | 2 | 2 | 4 | | 2008 | 3 | 2 | 5 | | 2009 | 1 | 2 | 3 | | 2010 | 2 | 0 | 2 | | 2011 | 1 | 1 | 2 | | 2012 | 0 | 2 | 2 | | 2013 | 1 | 4 | 5 | | 2014 | 0 | 2 | 2 | | 2015 | 1 | 1 | 2 | | 2016 | 3 | 2 | 5 | | 2017 | 2 | 2 | 4 | | 2018 | 0 | 1 | 1 | | 2019 | 1 | 1 | 2 | | 2020 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Neurotransmitter Agents" by people in Profiles.
-
Imamura T, Mehta P, Nguyen A, Chung B, Narang N, Rodgers D, Raikhelkar J, Smith B, Song T, Ota T, Jeevanandam V, Kim G, Sayer G, Uriel N. Neurohormonal Blockade During Left Ventricular Assist Device Support. ASAIO J. 2020 08; 66(8):881-885.
-
Kumar A, Basak S, Rao S, Gicheru Y, Mayer ML, Sansom MSP, Chakrapani S. Mechanisms of activation and desensitization of full-length glycine receptor in lipid nanodiscs. Nat Commun. 2020 07 27; 11(1):3752.
-
Serrano-Saiz E, Gulez B, Pereira L, Gendrel M, Kerk SY, Vidal B, Feng W, Wang C, Kratsios P, Rand JB, Hobert O. Modular Organization of Cis-regulatory Control Information of Neurotransmitter Pathway Genes in Caenorhabditis elegans. Genetics. 2020 07; 215(3):665-681.
-
De Rossi P, Nomura T, Andrew RJ, Masse NY, Sampathkumar V, Musial TF, Sudwarts A, Recupero AJ, Le Metayer T, Hansen MT, Shim HN, Krause SV, Freedman DJ, Bindokas VP, Kasthuri N, Nicholson DA, Contractor A, Thinakaran G. Neuronal BIN1 Regulates Presynaptic Neurotransmitter Release and Memory Consolidation. Cell Rep. 2020 03 10; 30(10):3520-3535.e7.
-
Shields EP, Weber SG. A crosslinked, low pH-stable, mixed-mode cation-exchange like stationary phase made using the thiol-yne click reaction. J Chromatogr A. 2020 May 10; 1618:460851.
-
Baertsch NA, Ramirez JM. Insights into the dynamic control of breathing revealed through cell-type-specific responses to substance P. Elife. 2019 12 05; 8.
-
Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation. 2019 04 16; 139(16):e840-e878.
-
Kratsios P, Hobert O. Nervous System Development: Flies and Worms Converging on Neuron Identity Control. Curr Biol. 2018 10 08; 28(19):R1154-R1157.
-
Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S. Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nat Rev Drug Discov. 2018 04; 17(4):280-299.
-
Zhou Q, Zhou P, Wang AL, Wu D, Zhao M, Südhof TC, Brunger AT. The primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis. Nature. 2017 08 24; 548(7668):420-425.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|